Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04567225 · ClinicalTrials.gov registry record · Phase 4
Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
A Phase 4 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 39
- Enrollment target
NCT04567225 is a Phase 4 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 39 participants.
The verdict
NCT04567225, a Phase 4 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 39 participants
- Enrollment target
Study Summary
Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
Interventions
- OTHER IV insulin infusion
- DRUG Early Glargine
- DRUG Late Glargine
- OTHER IV fluid and electrolytes replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-08-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04567225
The ClinicalTrials.gov registry entry for NCT04567225 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which IV insulin infusion is the first listed.
NCT04567225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04567225 about?
NCT04567225 is a clinical study titled "Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management". Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
What is the current status of trial NCT04567225?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 39 participants. The study started on 2020-10-01. Estimated completion is 2021-08-27.
What interventions are being tested in trial NCT04567225?
The interventions under investigation include: IV insulin infusion (OTHER), Early Glargine (DRUG), Late Glargine (DRUG), IV fluid and electrolytes replacement (OTHER).
Who is sponsoring clinical trial NCT04567225?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.